
Life Sciences
Inside: Drug Developers Are Abandoning Centralized Data Lakes for Federated Ledgers
Pharmaceutical companies now lose less IP to distributed compute than to cloud breaches, reversing two decades of centralization economics.
·8 min read
In-depth analysis of how ColdAI's strategic intelligence, AI systems and distributed ledger infrastructure are transforming the Life Sciences sector. Authored by Dr. Shayan Salehi H.C.

Pharmaceutical companies now lose less IP to distributed compute than to cloud breaches, reversing two decades of centralization economics.

Agentic clinical trial orchestration and distributed patient cohorts have inverted the traditional cost curve—and regulators are watching closely.